Javascript must be enabled to continue!
NT-proBNP and the Diagnosis of Heart Failure: A Pooled Analysis of Three European Epidemiological Studies
View through CrossRef
Abstract
Many studies have shown that the B-type natriuretic peptides (BNP and NT-proBNP) are proven diagnostic markers for heart failure due to left ventricular systolic dysfunction. The manner in which they are to be used is still being unravelled; most single centre studies have chosen the best concentration of the peptide on ROC analysis as their cut-point resulting in numerous different values for both BNP and NT-proBNP appearing in the literature. We report a different approach of defining an age and sex corrected abnormal concentration for NT-proBNP, derived from normal individuals within a large sample of 3051 subjects pooled from three European epidemiology studies and applying that to the entire population to detect HF and LVD. Three thousand and fifty one subjects were studied. Of these 10% (305) had significant LVD and 3.1% (94) had HF. The median concentrations of NT-proBNP (IQR) in normals, those with LVD and in heart failure subjects were 20 pg/ml (10.30), 117.3 pg/ml (28.145) and 269.6 pg/ml (54.323), P<0.001, respectively. The area under the ROC curve for NT-proBNP for the detection of ‘heart failure’ was 0.85 and 0.69 for LVD. NT-proBNP was an independent predictor of the presence of HF on multivariate analysis. An abnormal NT-proBNP was defined as being >95th centile for normals, age and sex corrected, and diagnosed HF with a sensitivity of 75% and a negative predictive value of 99%. In an additional analysis in a breathless subgroup of our population, in 30% a raised NT-proBNP concentration could be explained by HF due to LVD, in another 64% the high BNP level was associated with some other structural of functional cardiac abnormality or renal impairment. We were unable to assign a possible cause to the high NT-proBNP values in 5.9% of this breathless subgroup of the population. An abnormal NT-proBNP concentration is an accurate diagnostic test both for the exclusion of HF in the population and in ruling out LVD in breathless subjects. An elevated NT-proBNP merely indicates the presence of ‘cardio-renal distress’ and should prompt referral for further investigation.
Oxford University Press (OUP)
Title: NT-proBNP and the Diagnosis of Heart Failure: A Pooled Analysis of Three European Epidemiological Studies
Description:
Abstract
Many studies have shown that the B-type natriuretic peptides (BNP and NT-proBNP) are proven diagnostic markers for heart failure due to left ventricular systolic dysfunction.
The manner in which they are to be used is still being unravelled; most single centre studies have chosen the best concentration of the peptide on ROC analysis as their cut-point resulting in numerous different values for both BNP and NT-proBNP appearing in the literature.
We report a different approach of defining an age and sex corrected abnormal concentration for NT-proBNP, derived from normal individuals within a large sample of 3051 subjects pooled from three European epidemiology studies and applying that to the entire population to detect HF and LVD.
Three thousand and fifty one subjects were studied.
Of these 10% (305) had significant LVD and 3.
1% (94) had HF.
The median concentrations of NT-proBNP (IQR) in normals, those with LVD and in heart failure subjects were 20 pg/ml (10.
30), 117.
3 pg/ml (28.
145) and 269.
6 pg/ml (54.
323), P<0.
001, respectively.
The area under the ROC curve for NT-proBNP for the detection of ‘heart failure’ was 0.
85 and 0.
69 for LVD.
NT-proBNP was an independent predictor of the presence of HF on multivariate analysis.
An abnormal NT-proBNP was defined as being >95th centile for normals, age and sex corrected, and diagnosed HF with a sensitivity of 75% and a negative predictive value of 99%.
In an additional analysis in a breathless subgroup of our population, in 30% a raised NT-proBNP concentration could be explained by HF due to LVD, in another 64% the high BNP level was associated with some other structural of functional cardiac abnormality or renal impairment.
We were unable to assign a possible cause to the high NT-proBNP values in 5.
9% of this breathless subgroup of the population.
An abnormal NT-proBNP concentration is an accurate diagnostic test both for the exclusion of HF in the population and in ruling out LVD in breathless subjects.
An elevated NT-proBNP merely indicates the presence of ‘cardio-renal distress’ and should prompt referral for further investigation.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
Objectives
The research is to find the related risk factors that may lead to PPCM through analysing and summarising the general clinical characteristics of PPCM p...
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
Objectives
This study was designed to investigate whether admission N-terminal pro-brain natriuretic peptide (NT-proBNP) increase the prognostic accuracy of Globa...
Diagnostic value and risk correlation of serum heart-type fatty acid-binding protein (H-FABP) and osteoprotegerin (OPG) in chronic heart failure
Diagnostic value and risk correlation of serum heart-type fatty acid-binding protein (H-FABP) and osteoprotegerin (OPG) in chronic heart failure
Background: To analyse the value of H-FABP and OPG in determining the severity of heart function in those suffering from long-term heart failure. Methods: A total of 196 patients w...
Plasmatic NT-proBNP is strongly associated with atrial fibrillation in patients with Implantable cardioverter defibrillator
Plasmatic NT-proBNP is strongly associated with atrial fibrillation in patients with Implantable cardioverter defibrillator
Abstract
Background and objectives
Atrial fibrillation is common in patients with chronic heart failure and associated with poor...
Clinical impact of the determination of natriuretic peptides on long-term follow-up of patients treated in the Heart Failure Unit
Clinical impact of the determination of natriuretic peptides on long-term follow-up of patients treated in the Heart Failure Unit
Abstract
Introduction
The use of natriuretic peptides has spread in recent years as a diagnostic tool in patients with heart fai...
CORRELATION BETWEEN NT-PROBNP AND ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH ARRHYTHMIAS
CORRELATION BETWEEN NT-PROBNP AND ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH ARRHYTHMIAS
Background: Arrhythmias are a significant public health burden, associated with increased morbidity and mortality. NT-proBNP, a biomarker of cardiac stress, has been shown to be el...
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
Abstract
BACKGROUND AND AIMS
Patients with chronic kidney disease (CKD) stage 5 on haemodialysis are at a high risk of cardiovas...

